Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Egbert Oosterwijk

Showing results (21-30 of 190) with videos related to

Pageof 19
Sort By:
International Journal of Molecular Sciences|June 14, 2013
Application of monoclonal antibody G250 recognizing carbonic anhydrase IX in renal cell carcinomaJeannette C Oosterwijk-Wakka, Otto C Boerman, Peter F A Mulders, et al.
Advanced Healthcare Materials|January 14, 2022
A Temperature-Based Easy-Separable (TempEasy) 3D Hydrogel Coculture SystemZhaobao Zhang, Wen Chen, Dorien M Tiemessen, et al.
BJU International|July 5, 2007
Prognostic impact of carbonic anhydrase IX expression in human renal cell carcinomaJohanna Sandlund, Egbert Oosterwijk, Kjell Grankvist, et al.
Biomacromolecules|January 5, 2019
Synthetic Extracellular Matrices with Nonlinear Elasticity Regulate Cellular OrganizationKaizheng Liu, Silvia M Mihaila, Alan Rowan, et al.
Tissue Engineering. Part C, Methods|September 1, 2012
Zero echo time magnetic resonance imaging of contrast-agent-enhanced calcium phosphate bone defect fillersYi Sun, Manuela Ventura, Egbert Oosterwijk, et al.
Virchows Archiv : an International Journal of Pathology|June 22, 2011
Overexpression of carbonic anhydrase IX (CAIX) is an independent unfavorable prognostic marker in endometrioid ovarian cancerMatthias Choschzick, Egbert Oosterwijk, Volkmar Müller, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 26, 2022
Combining Targeted Radionuclide Therapy and Immune Checkpoint Inhibition for Cancer TreatmentSimone C Kleinendorst, Egbert Oosterwijk, Johan Bussink, et al.
Cancer Biotherapy & Radiopharmaceuticals|September 30, 2004
Pharmacokinetics and tumor targeting of 131I-labeled F(ab')2 fragments of the chimeric monoclonal antibody G250: preclinical and clinical pilot studiesAdrienne Brouwers, Peter Mulders, Egbert Oosterwijk, et al.
World Journal of Urology|May 17, 2018
A placebo-controlled efficacy study of the intravesical immunomodulators TMX-101 and TMX-202 in an orthotopic bladder cancer rat modelJohannes Falke, Christina A Hulsbergen-van de Kaa, Roberto Maj, et al.
Tissue Engineering. Part B, Reviews|February 23, 2019
Reconstruction Strategies of the Ureter and Urinary Diversion Using Tissue Engineering ApproachesHeinz P Janke, Paul K J D de Jonge, Wout F J Feitz, et al.
Pageof 19

Showing results (21-30 of 190) with videos related to

Sort By:
Pageof 19
International Journal of Molecular Sciences|June 14, 2013
Application of monoclonal antibody G250 recognizing carbonic anhydrase IX in renal cell carcinomaJeannette C Oosterwijk-Wakka, Otto C Boerman, Peter F A Mulders, et al.
Advanced Healthcare Materials|January 14, 2022
A Temperature-Based Easy-Separable (TempEasy) 3D Hydrogel Coculture SystemZhaobao Zhang, Wen Chen, Dorien M Tiemessen, et al.
BJU International|July 5, 2007
Prognostic impact of carbonic anhydrase IX expression in human renal cell carcinomaJohanna Sandlund, Egbert Oosterwijk, Kjell Grankvist, et al.
Biomacromolecules|January 5, 2019
Synthetic Extracellular Matrices with Nonlinear Elasticity Regulate Cellular OrganizationKaizheng Liu, Silvia M Mihaila, Alan Rowan, et al.
Tissue Engineering. Part C, Methods|September 1, 2012
Zero echo time magnetic resonance imaging of contrast-agent-enhanced calcium phosphate bone defect fillersYi Sun, Manuela Ventura, Egbert Oosterwijk, et al.
Virchows Archiv : an International Journal of Pathology|June 22, 2011
Overexpression of carbonic anhydrase IX (CAIX) is an independent unfavorable prognostic marker in endometrioid ovarian cancerMatthias Choschzick, Egbert Oosterwijk, Volkmar Müller, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 26, 2022
Combining Targeted Radionuclide Therapy and Immune Checkpoint Inhibition for Cancer TreatmentSimone C Kleinendorst, Egbert Oosterwijk, Johan Bussink, et al.
Cancer Biotherapy & Radiopharmaceuticals|September 30, 2004
Pharmacokinetics and tumor targeting of 131I-labeled F(ab')2 fragments of the chimeric monoclonal antibody G250: preclinical and clinical pilot studiesAdrienne Brouwers, Peter Mulders, Egbert Oosterwijk, et al.
World Journal of Urology|May 17, 2018
A placebo-controlled efficacy study of the intravesical immunomodulators TMX-101 and TMX-202 in an orthotopic bladder cancer rat modelJohannes Falke, Christina A Hulsbergen-van de Kaa, Roberto Maj, et al.
Tissue Engineering. Part B, Reviews|February 23, 2019
Reconstruction Strategies of the Ureter and Urinary Diversion Using Tissue Engineering ApproachesHeinz P Janke, Paul K J D de Jonge, Wout F J Feitz, et al.
Pageof 19